Shanghai Pharmaceuticals Gets Nod to Market Aripiprazole Tablets in Philippines; Shares Up 1%

MT Newswires Live

2025/09/15

Shanghai Pharmaceuticals Holding (SHA:601607, HKG:2607) received approval to market its aripiprazole tablets in the Philippines after obtaining a drug registration certificate, according to a Saturday filing on the Shanghai bourse.

The Chinese pharmaceutical company's Shanghai shares rose less than 1% during Monday's midday trade.

The drug is mainly used to treat schizophrenia and manic episodes of bipolar disorder. The antipsychotic drug can also be used as adjunctive therapy for depression.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2567028194"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2567028194\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2567028194?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-15 12:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2567028194","market":"sg","top_or_hot":-1,"title":"Shanghai Pharmaceuticals Gets Nod to Market Aripiprazole Tablets in Philippines; Shares Up 1%","media":"MT Newswires Live","content":"<html><body><p> Shanghai Pharmaceuticals Holding (SHA:601607, HKG:2607) received approval to market its aripiprazole tablets in the Philippines after obtaining a drug registration certificate, according to a Saturday filing on the Shanghai bourse.</p><p>The Chinese pharmaceutical company's Shanghai shares rose less than 1% during Monday's midday trade.</p><p>The drug is mainly used to treat schizophrenia and manic episodes of bipolar disorder. The antipsychotic drug can also be used as adjunctive therapy for depression.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Pharmaceuticals Gets Nod to Market Aripiprazole Tablets in Philippines; Shares Up 1%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Pharmaceuticals Gets Nod to Market Aripiprazole Tablets in Philippines; Shares Up 1%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-09-15 12:04</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Shanghai Pharmaceuticals Holding (SHA:601607, HKG:2607) received approval to market its aripiprazole tablets in the Philippines after obtaining a drug registration certificate, according to a Saturday filing on the Shanghai bourse.</p><p>The Chinese pharmaceutical company's Shanghai shares rose less than 1% during Monday's midday trade.</p><p>The drug is mainly used to treat schizophrenia and manic episodes of bipolar disorder. The antipsychotic drug can also be used as adjunctive therapy for depression.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0184","symbol_name":"上海國資改革","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2567028194","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2567028194","pubTimestamp":1757909084,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shanghai Pharmaceuticals Holding  received approval to market its aripiprazole tablets in the Philippines after obtaining a drug registration certificate, according to a Saturday filing on the Shanghai bourse.The Chinese pharmaceutical company's Shanghai shares rose less than 1% during Monday's midday trade.The drug is mainly used to treat schizophrenia and manic episodes of bipolar disorder. The antipsychotic drug can also be used as adjunctive therapy for depression.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"601607":"上海医药","BK0184":"上海国资改革","BK0175":"白马股","BK0097":"医药电商","02607":"上海医药","BK0099":"上海本地重组","BK0028":"国家队","BK1197":"保健护理产品经销商","BK0020":"浦东新区","BK0183":"MSCI概念","BK0209":"零售","BK0188":"融资融券","BK0012":"证金概念","BK0196":"行业龙头","BK0187":"一线龙头"},"translate_title":"上海医药获准在菲律宾上市阿立哌唑片；股价上涨1%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":0.9,"02607":0.9},"content_text":"Shanghai Pharmaceuticals Holding (SHA:601607, HKG:2607) received approval to market its aripiprazole tablets in the Philippines after obtaining a drug registration certificate, according to a Saturday filing on the Shanghai bourse.The Chinese pharmaceutical company's Shanghai shares rose less than 1% during Monday's midday trade.The drug is mainly used to treat schizophrenia and manic episodes of bipolar disorder. The antipsychotic drug can also be used as adjunctive therapy for depression.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}